Cancer Care Specialists of Central Illinois

Clinical research site in Swansea, Illinois

Part of Cancer Care Specialists of Central Illinois

As of July 2026, 1 paid clinical trial is recruiting at Cancer Care Specialists of Central Illinois in Swansea, Illinois. Active studies at this site focus on B-Cell Non-Hodgkins Lymphoma alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Cancer Care Specialists of Central Illinois (1)

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

for B-Cell Non-Hodgkins Lymphoma

33 locations incl. Anchorage

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT06806033·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Explore more

Paid clinical trials in Swansea, IL · Illinois clinical trials